drugset / Trial / NCT00986856

Fucidin® Cream in the Treatment of Impetigo

NCT00986856

Phase 4 Terminated 58 enrolled LEO Pharma
RandomizedParallel-groupDouble-blindTreatment

Summary

To investigate the clinical and bacteriological efficacy of Fucidin® cream in the treatment of impetigo in paediatric patients. To assess the validity of in vitro susceptibility-testing of S. aureus to fusidic acid as a prediction of clinical and bacteriological outcome in impetigo patients treated with Fucidin® cream. To investigate the genetic relationship between S. aureus-strains isolated from impetigo patients.

Timeline

Start
2004-05
Primary completion
2005-03
Completion
2005-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Fusidic Acid Unknown

Indications